CompagOs AG

CompagOs, a Swiss spin-off from ETH Zürich, is advancing bone health by helping doctors to match the right patients with the right treatments and by helping researchers to translate research findings into clinical applications. Employing innovative 3D printing technology, we produce reliable and reproducible bone organoids, called Bon3OID™, that are mineralized and multicellular. Our goal is to drive advancements in the field of drug discovery, preclinical patient stratification, predictive diagnostics and personalized medicine. We are developing and offering Bon3OID™ based products and services in the following areas: -Healthy bone - Fracture - Bone metastasis - Osteosarcoma - Osteogenesis imperfecta - Osteoporosis